FiberSpin
Revolutionary products for aesthetic and regenerative medicine.
Company Overview
Snapshot
Founded in May 2015 by Eyal Sheetrit, FiberSpin operates with 1–10 employees. The company has raised $100K across one funding round, focusing on developing innovative solutions in aesthetic and regenerative medicine.
Business overview
FiberSpin is a Health Tech & Life Sciences company pioneering breakthrough solutions in aesthetic and regenerative medicine. Leveraging cutting-edge advances in materials science, the company has developed an innovative platform that mimics the look and function of natural human tissue. This technology is being translated into a portfolio of products designed for patients experiencing soft tissue loss due to aging, cancer, or metabolic disease, aiming to restore both form and function with minimal downtime. FiberSpin operates in the Medical Devices and Medical Treatment & Therapeutics sectors, targeting healthcare providers and patients.
Log in to access full profile ›Company Intelligence Q&A
- What is FiberSpin's primary focus?
- FiberSpin is focused on pioneering breakthrough solutions in aesthetic and regenerative medicine, utilizing advanced materials science to develop products that mimic natural human tissue.
- Who founded FiberSpin?
- FiberSpin was founded by Eyal Sheetrit in May 2015.
- What is FiberSpin's core technology?
- FiberSpin's core technology involves an innovative platform built on materials science that mimics the look and function of natural human tissue, specifically for soft tissue regeneration.
- What markets does FiberSpin target?
- FiberSpin targets the aesthetic and regenerative medicine markets, serving millions of patients who experience soft tissue loss due to aging, cancer, or metabolic disease, as well as healthcare providers in these areas.
- What is FiberSpin's current product offering?
- FiberSpin's product, FiberBloom, is currently in the R&D stage, focusing on developing solutions for soft tissue regeneration.